Sellas Gets Green Light to Continue Phase 3 REGAL Trial of GPS in AML After Positive Data Review
RefinitivOkuma süresi: 1 dakikadan kısa
Sellas Life Sciences Group Inc 
SLS:
SELLAS LIFE SCIENCES ANNOUNCES INDEPENDENT DATA MONITORING COMMITTEE PERIODIC REVIEW AND POSITIVE RECOMMENDATION TO CONTINUE PIVOTAL PHASE 3 REGAL TRIAL OF GPS IN AML WITHOUT MODIFICATION
SELLAS LIFE SCIENCES GROUP INC - IDMC FINDS NO SAFETY CONCERNS IN GPS TRIAL
SELLAS LIFE SCIENCES GROUP INC: FINAL ANALYSIS ANTICIPATED BY YEAR-END UPON OCCURRENCE OF 80 EVENTS
Bu haberi okumak için giriş yapın veya sonsuza kadar ücretsiz bir hesap oluşturun